Healthy women needed to compare two versions of experimental drug
NCT ID NCT07544628
First seen Apr 26, 2026 · Last updated Jun 22, 2026 · Updated 10 times
Summary
This study tests whether a new wet-granulation tablet of the drug navlimetostat works the same as the current dry-granulation tablet. It involves 64 healthy women who are not of childbearing potential. Participants will receive both tablet forms at different times, and researchers will measure drug levels in the blood and check for side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
CenExel iResearch - Decatur
RECRUITINGDecatur, Georgia, 30030, United States
Contact Phone: •••-•••-••••
-
Local Institution - 0003
NOT_YET_RECRUITINGDecatur, Georgia, 30030, United States
Contact
-
PPD
RECRUITINGAustin, Texas, 78744, United States
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
navlimetostat
What this could lead to
If successful, this study could confirm that a new tablet formulation of navlimetostat works the same as the original, supporting future trials for diseases like cancer.
What could go wrong
This is an early-phase study in healthy volunteers, not patients. It only checks how the drug is processed, not whether it treats any disease. Results may not predict effectiveness in sick people.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.